Matwings Raises Series A Funding to Advance AI-Driven Protein Design
Matwings is one of the earliest companies focused on AI protein models.
Company Name: Shanghai Matwings Technology Co., Ltd.
Location: Shanghai, China
Industry: AI-Driven Protein Design
Funding Details:
Amount: Tens of millions of USD (Series A)
Investor: Qiming Venture Partners (Lead)
Purpose of Investment:
The funds will support the continued development of Matwings’ AI-powered protein design platform, AccelProtein™, and foster global partnerships for product development and commercialization.
Leadership:
Founded by: Elite team from Shanghai Jiao Tong University
Product:
Matwings’ proprietary AccelProtein™ platform pioneers AI-driven protein engineering by directly predicting protein functionality beyond structural data. Key features include:
- Functionality Prediction: Offering a new approach to identify high-functioning proteins.
- Protein Engineering: Development of key enzymes and proteins for CMC, innovative biologics, and synthetic biology applications.
Impact:
To date, Matwings has engineered over 30 proprietary or co-developed proteins and is actively engaged in more than 40 ongoing projects across pharmaceutical and synthetic biology industries.
About the Company:
Matwings is one of the earliest companies focused on AI protein models. Its cutting-edge technology is reshaping protein engineering by accelerating the discovery and design of functional proteins for diverse applications.
By seeking global partnerships and leveraging strategic investment, Matwings aims to drive innovation and commercialization in AI-driven protein design worldwide.
